Evidence map›Paper›PMID 41779619›Full record

ArticleInternational braz j urol : official journal of the Brazilian Society of Urology

Safe to Spare? Predictors of Oncological Safety for Nerve-Sparing Technique during Robot-Assisted Radical Prostatectomy in High-Risk Prostate Cancer. Insight from a High Volume Center with Centralized mpMRI Review.

Luca Lambertini, Fabrizio Di Maida, Giulia Carli, Antonio Andrea Grosso, Sofia Giudici, Anna Cadenar, Simone Sforza, Daniele Paganelli, Filippo Lipparini, Neliana Kucuku and 11 more

Abstract read
In one paragraph

Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Luca LambertiniDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Fabrizio Di MaidaDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Giulia CarliDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Antonio Andrea GrossoDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Sofia GiudiciDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Anna CadenarDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Simone SforzaDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Daniele PaganelliDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Filippo LippariniDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Neliana KucukuDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Rossella CatanzaroDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Francesca ConteDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Francesco Lupo ConteDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Matteo SalviDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Simone AgostiniDepartment of Radiology, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Fausto De NiscoDepartment of Radiology, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Gabriella NesiDepartment of Health Sciences, Division of Pathological Anatomy, University of Florence, Florence, Italy.
Rino OritiDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Gianni VittoriDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Andrea MinerviniDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.
Andrea MariDepartment of Experimental and Clinical Medicine, University of Florence - Unit of Urology and Andrology, Careggi Hospital, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate patterns and imaging-based predictors of positive surgical margins (PSMs) in patients with high-risk prostate cancer (PCa) undergoing nerve-sparing (NS) robot-assisted radical prostatectomy (RARP). MATERIALS AND

methodsWe retrospectively analyzed 1,235 consecutive patients with high-risk PCa treated with RARP between 2022 and 2024 at a high-volume tertiary referral center. Among them, 533 patients underwent preoperative multiparametric MRI (mpMRI) reviewed by two expert uro-radiologists and MRI-ultrasound fusion biopsy. A per-side analysis was performed to identify predictors of ipsilateral PSMs in cases where neurovascular bundle (NVB) preservation was attempted. Biochemical recurrence (BCR) was assessed, and multivariable logistic regression was used to determine independent predictors of PSMs.

resultsOverall, 36.1% of patients underwent non-nerve-sparing surgery, 49.5% unilateral NS, and 14.4% bilateral NS. Nerve sparing was performed on 418 surgical sides, with ipsilateral PSMs detected in 90 (21.5%). Sides with and without PSMs showed comparable nerve-sparing techniques (intra- vs interfascial) and similar 3-year BCR-free survival rates (68% vs. 69%) at a median follow-up of 36 months, although earlier biochemical failure at lower PSA thresholds was more frequent in PSM-positive sides. On multivariable analysis, larger prostate volume, apical tumor location, peripheral zone involvement, greater lesion diameter, and extracapsular extension on mpMRI were independently associated with an increased risk of ipsilateral PSMs.

conclusionsNerve-sparing RARP may be feasible in carefully selected high-risk PCa patients. The integration of mpMRI-based predictors can enhance patient selection, optimizing the balance between oncologic safety and functional preservation. Prospective studies are warranted to validate these findings and minimize selection bias.

Indexed as

Organ Sparing TreatmentsProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedHumansMaleMargins of ExcisionMiddle AgedMultiparametric Magnetic Resonance ImagingNeoplasm Recurrence, LocalProstateRetrospective StudiesRisk FactorsTreatment OutcomeMethodsProstatic NeoplasmsRobotic Surgical Procedures

Identifiers

PMID41779619
PMCPMC13124193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.